Overview Nicotine Patch - Multidose Bioequivalence Study Status: Completed Trial end date: 2012-09-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare the relative bioavailability of nicotine following repeated applications of a new transdermal formulation to that of a reference formulation. Up to day 7 Phase: Phase 1 Details Lead Sponsor: Pierre Fabre MedicamentTreatments: Nicotine